(JKI) iShares Morningstar Mid-Cap - Ratings and Ratios
Equities, Mid-Cap, Value
Dividends
| Dividend Yield | 2.16% |
| Yield on Cost 5y | 1.18% |
| Yield CAGR 5y | -19.03% |
| Payout Consistency | 89.6% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 12.8% |
| Value at Risk 5%th | 21.1% |
| Relative Tail Risk | -0.28% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.31 |
| Alpha | -4.39 |
| CAGR/Max DD | 0.53 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.367 |
| Beta | 0.753 |
| Beta Downside | 0.863 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.65% |
| Mean DD | 4.95% |
| Median DD | 3.82% |
Description: JKI iShares Morningstar Mid-Cap November 30, 2025
The iShares Morningstar Mid-Cap Value ETF (NASDAQ: JKI) aims to replicate the Morningstar US Mid-Cap Broad Value Index™, which selects U.S. mid-cap stocks that exhibit “value” traits according to Morningstar’s proprietary methodology. The fund invests at least 90 % of its net assets in the index constituents or their depository receipts, seeking to deliver returns that closely match the index’s performance.
As of the most recent filing, JKI manages roughly $2 billion in assets, carries an expense ratio of 0.25 %, and distributes a dividend yield near 2.1 % (annualized). The portfolio is weighted toward financials, industrials, and consumer discretionary-sectors that historically benefit when interest rates stabilize and corporate earnings growth resumes. Recent data show the mid-cap value segment has outperformed large-cap growth by about 1.5 percentage points over the past 12 months, a relative edge that tends to widen in a low-inflation environment.
If you want to see how ValueRay’s factor screens differ from Morningstar’s approach, a quick review of its methodology page could be a useful next step.
What is the price of JKI shares?
Over the past week, the price has changed by +1.96%, over one month by +3.32%, over three months by +5.16% and over the past year by +8.91%.
Is JKI a buy, sell or hold?
What are the forecasts/targets for the JKI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 89 | 6.1% |
JKI Fundamental Data Overview December 02, 2025
Beta = 1.19
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 896.1m USD (896.1m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 896.1m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 896.1m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.79% (E(896.1m)/V(896.1m) * Re(8.79%) + (debt-free company))
Discount Rate = 8.79% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for JKI ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle